Recent Episodes
A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke
Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL
CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities
Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center
CAR T-cell Therapy: A 60,000 Foot View
Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
Caring for the patient with CLL with Susan O’Brien, MD
Susan O’Brien, MD, University of California, Irvine, CA
An Overview of the Beat AML® Master Trial: Pioneering Treatment Options and Patient Services
Amy Burd, PhD, Vice President of Research and Strategy, and Alissa Gentile, MSN, RN, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society
Unique Challenges for Young Adult Cancer Survivors: What You Should Know
Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI
Categories
- All Episodes (91)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (30)
- Genomics (3)
- Health Equity (7)
- Leukemia (21)
- Lymphoma (12)
- Minimal Residual Disease (MRD) (3)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (11)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
